Skip to content
New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Update gene info processing for druggability revamp #162

Conversation

beatrizsaldana
Copy link
Member

@beatrizsaldana beatrizsaldana commented Dec 4, 2024

AG-863: Update gene_info processing for druggability revamp

Changes

  • Removed old druggability input file (syn13363443.11) from gene_info files in config and test_config
  • Removed old druggability input file (syn13363443.11) from gene_info provenance in config and test_config
  • Updated gene_metadata version number from 13 to 14 in config and test_config
  • Used new druggability source file (syn64123611.1) in config, call it pharos_classes
  • Updated druggability custom transform to keep only the pharos_class object
  • Updated gene_info druggability tests and testing assets
  • Updated druggability gx validation

Acceptance Criteria

  • ADT configs incorporate the appropriate source file/provenance updates
  • transform_gene_info is updated as required to produce the target data structure
  • custom transform tests are added/updated as required
  • GX validation is adjusted as required

Copy link

sonarqubecloud bot commented Dec 6, 2024

@beatrizsaldana beatrizsaldana changed the title Beatrizsaldana/ag 1564/adt update gene info processing for druggability revamp Update gene info processing for druggability revamp Dec 6, 2024
@beatrizsaldana beatrizsaldana marked this pull request as ready for review December 7, 2024 00:11
@beatrizsaldana beatrizsaldana requested a review from a team as a code owner December 7, 2024 00:11
Sign up for free to join this conversation on GitHub. Already have an account? Sign in to comment
Labels
None yet
Projects
None yet
Development

Successfully merging this pull request may close these issues.

1 participant